Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

56.70
-2.4500-4.14%
Pre-market: 56.27-0.4304-0.76%04:39 EDT
Volume:1.03M
Turnover:58.50M
Market Cap:3.47B
PE:-44.64
High:58.92
Open:58.58
Low:56.12
Close:59.15
52wk High:66.06
52wk Low:23.30
Shares:61.15M
Float Shares:59.26M
Volume Ratio:0.78
T/O Rate:1.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2703
EPS(LYR):-1.2987
ROE:-16.79%
ROA:-13.49%
PB:7.60
PE(LYR):-43.66

Loading ...

Earning Preview: Twist Bioscience Corp revenue expected to increase by 17.03% this quarter, and institutional views are bullish

Earnings Agent
·
Apr 27

Twist Bioscience director Melissa Starovasnik sells 500 shares worth $30,915

Reuters
·
13 hours ago

Twist Bio CFO Adam Laponis disposes of 4,000 shares worth $240,000

Reuters
·
Apr 22

Press Release: Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026

Dow Jones
·
Apr 21

Twist Bioscience CFO Adam Laponis sells 3,000 shares worth $165,000

Reuters
·
Apr 17

Twist Bioscience Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 15

CORRECTED-Amazon launches AI research tool to speed early-stage drug discovery

Reuters
·
Apr 14

Twist Bioscience Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Apr 07

Twist Bioscience Director Melissa Starovasnik sells USD 51 million common shares

Reuters
·
Apr 04

Twist Bioscience Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 30

Twist Bioscience price target raised to $55 from $50 at Guggenheim

TIPRANKS
·
Mar 30

CORRECTED-UK's Aptamer H1 revenue rises on new pharma contracts

Reuters
·
Mar 25

Is Twist Bioscience (TWST) Using Invenra Deal To Quietly Redefine Its Biologics Platform Strategy?

Simply Wall St.
·
Feb 28

Twist Bioscience Expands Antibody Discovery With Invenra Bispecific Platform Deal

Simply Wall St.
·
Feb 26

Twist Bioscience Stock (TWST) Tumbles after Senior Executive Offloads $2M in Shares

TIPRANKS
·
Feb 21

Twist Bioscience SVP of Human Resources Paula Green Disposes of Common Shares

Reuters
·
Feb 20

Twist Bioscience President and COO Patrick John Finn Disposes of Common Shares

Reuters
·
Feb 20

Twist Bioscience to Join Fireside Chats at TD Cowen, Barclays and Leerink Healthcare Investor Conferences

Reuters
·
Feb 18

Twist Bioscience Licenses Invenra's B-Body Platform to Expand Bispecific Antibody Discovery Services

MT Newswires Live
·
Feb 17

BRIEF-Twist Bioscience Expands Antibody Discovery Offering With Bispecific Licensing Agreement

Reuters
·
Feb 17